Clinical Trial: An Open-label, Parallel-group, Multicenter Clinical Study to Evaluate the Pharmacokinetics and Safety of SYHX1901 Tablets in Participants with Mild, Moderate Hepatic Impairment and Matched Controls with Normal Hepatic Function (China)

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An Open-label, Parallel-group, Multicenter Clinical Study to Evaluate the Pharmacokinetics and Safety of SYHX1901 Tablets in Participants with Mild, Moderate Hepatic Impairment and Matched Controls with Normal Hepatic Function'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129491

Registration Time: 2026/08/05

Type: Interventional study

Primary Sponsor: Huashan Hospital, Fudan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336768

Published by HT Digital Content Services with permission from Health Daily Digest....